Neuroectodermal Tumors, Primitive
"Neuroectodermal Tumors, Primitive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially (i.e., NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL). This term is also occasionally used as a synonym for MEDULLOBLASTOMA. In general, these tumors arise in the first decade of life and tend to be highly malignant. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059)
MeSH Number(s)
C04.557.465.625.600.590
C04.557.470.670.590
C04.557.580.625.600.590
Concept/Terms
Neuroectodermal Tumors, Primitive- Neuroectodermal Tumors, Primitive
- Neuroectodermal Tumor, Primitive
- Primitive Neuroectodermal Tumor
- Primitive Neuroectodermal Tumors
- Tumor, Primitive Neuroectodermal
- Tumors, Primitive Neuroectodermal
- Primitive Neuroepithelial Neoplasms
- Neuroepithelial Tumors, Primitive
- Neuroepithelial Tumor, Primitive
- Primitive Neuroepithelial Tumor
- Primitive Neuroepithelial Tumors
- Tumor, Primitive Neuroepithelial
- Tumors, Primitive Neuroepithelial
- PNET
- PNETs
- Neoplasms, Primitive Neuroepithelial
- Neoplasm, Primitive Neuroepithelial
- Neuroepithelial Neoplasm, Primitive
- Primitive Neuroepithelial Neoplasm
- Neuroepithelial Neoplasms, Primitive
Below are MeSH descriptors whose meaning is more general than "Neuroectodermal Tumors, Primitive".
Below are MeSH descriptors whose meaning is more specific than "Neuroectodermal Tumors, Primitive".
This graph shows the total number of publications written about "Neuroectodermal Tumors, Primitive" by people in Harvard Catalyst Profiles by year, and whether "Neuroectodermal Tumors, Primitive" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1994 | 3 | 4 | 7 |
| 1995 | 2 | 0 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 3 | 0 | 3 |
| 1999 | 3 | 0 | 3 |
| 2000 | 1 | 0 | 1 |
| 2001 | 3 | 0 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 3 | 1 | 4 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 2 | 0 | 2 |
| 2011 | 2 | 2 | 4 |
| 2012 | 4 | 1 | 5 |
| 2013 | 4 | 1 | 5 |
| 2014 | 3 | 0 | 3 |
| 2015 | 4 | 1 | 5 |
| 2016 | 5 | 0 | 5 |
| 2017 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 3 | 0 | 3 |
| 2022 | 8 | 0 | 8 |
Below are the most recent publications written about "Neuroectodermal Tumors, Primitive" by people in Profiles.
-
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161. Invest New Drugs. 2022 12; 40(6):1306-1314.
-
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials. Acta Neuropathol. 2022 10; 144(4):733-746.
-
Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort. Ann Surg. 2022 09 01; 276(3):522-531.
-
Tuberous sclerosis complex-associated nonfunctional pancreatic neuroendocrine tumors: Management and surgical outcomes. Am J Med Genet A. 2022 09; 188(9):2666-2671.
-
Everolimus with or without bevacizumab in advanced pNET: CALGB 80701 (Alliance). Endocr Relat Cancer. 2022 05 09; 29(6):335-344.
-
Predicting Novel Drug Candidates for Pancreatic Neuroendocrine Tumors via Gene Signature Comparison and Connectivity Mapping. J Gastrointest Surg. 2022 08; 26(8):1670-1678.
-
Minimally Invasive vs Open Pancreatectomy for Pancreatic Neuroendocrine Tumors: Multi-Institutional 10-Year Experience of 1,023 Patients. J Am Coll Surg. 2022 08 01; 235(2):315-330.
-
Ovarian Primitive Neuroectodermal Tumor: Are You Central or Peripheral? Int J Gynecol Pathol. 2022 Mar 01; 41(2):203-205.
-
The challenges in treating embryonal tumors with multilayered rosettes (ETMR) and other infant brain tumors. Neuro Oncol. 2022 01 05; 24(1):138-140.
-
Biomarkers for prognosis in pancreatic neuroendocrine tumors. Endocr Relat Cancer. 2021 10 19; 28(12):773-782.